Xue Liwei, Zhong Qing, Xu Nianjie, Zheng Yanping, Liu Yuanfen
Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Department of Gastric surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Eur J Radiol Open. 2024 May 22;12:100571. doi: 10.1016/j.ejro.2024.100571. eCollection 2024 Jun.
The patient safety of iodine contrast-enhanced pulmonary artery CT angiography (CTPA) is widely concerned. This study aimed to investigate the image quality and immediate patient safety of spectral CTPA using a lower-contrast dose pre-dual-flow injection method.
This retrospective study included 120 patients with suspected pulmonary embolisms who received spectral CTPA between February and December 2022. Patients were divided into normal contrast injection (Group A, n=60) and pre-dual-flow group (Group B, n=60). CT values of pulmonary arteries (PAs) at different levels, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR), arteriovenous separation performance, and beam hardening artifact (BHA) index of two sets of images were measured or calculated. The subjective image quality and immediate patient safety were also scored using the three-point method.
Group B had a contrast dose reduction by 42.5 % (60 vs. 34.5 mL). Radiation exposure dose was not statistically different between the two groups (P>0.05). CT values of different-level PAs on group B images were higher than those on group A images (P<0.05). Group B images had higher SNR and CNR, better arteriovenous separation between PA trunk and pulmonary vein, and lower BHA index on soft tissue and PA (all P<0.05). For subjective evaluation of image quality, group B had a better score in beam hardening artifact (P<0.05). For immediate patient safety, the score in comfortability was statistically higher in group B, with P<0.05.
Comparing with the normal injection method, pre-dual-flow spectral CTPA with a lower contrast dose injected results in better image quality and shows potential in patient-safety promotion.
碘对比剂增强肺动脉CT血管造影(CTPA)的患者安全性受到广泛关注。本研究旨在探讨采用低对比剂剂量预双流注射法的光谱CTPA的图像质量和患者即时安全性。
这项回顾性研究纳入了2022年2月至12月期间接受光谱CTPA检查的120例疑似肺栓塞患者。患者分为常规对比剂注射组(A组,n = 60)和预双流组(B组,n = 60)。测量或计算两组图像不同层面肺动脉(PA)的CT值、信噪比(SNR)和对比噪声比(CNR)、动静脉分离性能以及硬化伪影(BHA)指数。还采用三分法对主观图像质量和患者即时安全性进行评分。
B组对比剂剂量降低了42.5%(60 vs. 34.5 mL)。两组间辐射暴露剂量无统计学差异(P > 0.05)。B组图像不同层面PA的CT值高于A组图像(P < 0.05)。B组图像的SNR和CNR更高,PA主干与肺静脉之间的动静脉分离更好,软组织和PA的BHA指数更低(均P < 0.05)。在图像质量主观评价方面,B组在硬化伪影方面得分更高(P < 0.05)。在患者即时安全性方面,B组在舒适度方面的得分在统计学上更高,P < 0.05。
与常规注射方法相比,采用较低对比剂剂量注射的预双流光谱CTPA可产生更好的图像质量,并在促进患者安全方面显示出潜力。